GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
124 hedge funds and large institutions have $57.3M invested in Sanofi Contingent Value Rights in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
124
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.57M | |
| 2 | +$1.06M | |
| 3 | +$1.05M | |
| 4 |
GCM
Gruss Capital Management
New York
|
+$463K |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$78.5K |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$654K | |
| 3 | -$543K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$310K |
| 5 |
SC
Sophrosyne Capital
New York
|
-$151K |